Evidence Hub

Herbal Medicines in the Management of Migraine: Ethnobotanical Insights and Pharmacological Perspectives

R. Saraswathi, S. Anbazhagan, P. Muralidharan

Asian Journal of Research in Pharmaceutical Sciences, 2026

Abstract

Background: Migraine is a complex and recurrent neurovascular disorder that significantly impacts the quality of life and productivity of individuals worldwide. The limitations of conventional pharmacological therapies, including adverse effects and variable efficacy, have fuelled growing interest in herbal medicines as alternative or adjunct treatment options. Objective: This review aims to systematically explore and evaluate medicinal plants traditionally used for migraine management, with a focus on ethnobotanical origins, active phytoconstituents, mechanisms of action, and pharmacological validation. Methods: An extensive literature search was conducted using scientific databases such as PubMed, Scopus, and Web of Science to identify ethnomedicinal reports and experimental studies (in vitro, in vivo, and clinical trials) related to herbal treatments for migraine. Results: Numerous medicinal plants—including Tanacetum parthenium (feverfew), Petasites hybridus (butterbur), Zingiber officinale (ginger), and Mentha piperita (peppermint) etc., demonstrate antimigraine activity through diverse pharmacological actions such as anti-inflammatory effects, serotonergic modulation, CGRP inhibition, antioxidant activity, and vasodilation. The bioactive compounds implicated include sesquiterpene lactones, flavonoids, alkaloids, and essential oils. Conclusion: Herbal medicines present a promising and multifaceted approach to migraine management, drawing from rich ethnobotanical…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free